Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Almost everyone has taken an antibiotic for an infection during their lifetime. Now two new studies examine the role of antibiotics in disrupting gut microbes, and an increased risk for colon cancer. William Nelson, director of the Kimmel Cancer Center …
Do antibiotics increase someone’s risk for colon cancer? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
Aspirin’s benefits and harms in heart disease and colorectal cancer prevention have once again been examined by a federal workgroup, and Kimmel Cancer Center director William Nelson at Johns Hopkins says for younger people, who have been experiencing an uptick …
What is the role of aspirin in preventing colorectal cancer? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
Inherited genes for cancer may also predispose to a number of other health conditions, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says additional mutations acquired as a cancer develops also have a …
What can a new study of gene defects in cancer tell us? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 5:22 — 7.4MB)
Subscribe: RSS
HPV causes cancer, and we have an effective vaccine against it. Now the World Health Organization is advocating for a single dose of the vaccine in places where completing the two dose regimen is challenging. Johns Hopkins Kimmel Cancer Center …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Breakthrough infections, which occur in those who have been vaccinated against Covid-19, are more troubling for people with cancer than those without, a new study confirms. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, reviews the data. …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
People with cancer who have been vaccinated against Covid-19 remain at increased risk for infection compared with people who don’t have cancer, a very large new study reveals. Johns Hopkins Kimmel Cancer Center director William Nelson describes the findings. Nelson: …
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
An immunotherapy agent called nivolumab given before surgery in people with lung cancer dramatically lengthened the interval before cancer returned, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, is thrilled. Nelson: Will we …
